Predictors of response to opicinumab in acute optic neuritis

OBJECTIVE: The objective of this study was to evaluate prespecified and post hoc analyses in RENEW subgroups to identify participants more likely to benefit from opicinumab. METHODS: RENEW assessed the efficacy/safety of opicinumab versus placebo in participants with a first unilateral acute optic n...

Descripción completa

Detalles Bibliográficos
Autores principales: Cadavid, Diego, Balcer, Laura, Galetta, Steven, Aktas, Orhan, Ziemssen, Tjalf, Vanopdenbosch, Ludo J., Leocani, Letizia, Freedman, Mark S., Plant, Gordon T., Preiningerova, Jana Lizrova, Ziemssen, Focke, Massacesi, Luca, Chai, Yi, Xu, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6186935/
https://www.ncbi.nlm.nih.gov/pubmed/30349850
http://dx.doi.org/10.1002/acn3.620

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6186935/
https://www.ncbi.nlm.nih.gov/pubmed/30349850
http://dx.doi.org/10.1002/acn3.620

Ejemplares similares